NCT00669123View on ClinicalTrials.gov

Chondroitin Sulphate Efficay/Safety in Patients With Knee Osteoarthritis and Psoriasis

PHASE4CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

Not specified

Conditions
OsteoarthritisPsoriasisJoint DiseasesMuskuloskeletal DiseasesSkin Diseases
Interventions
DRUG

Chondroitin sulphate

Chondroitin sulphate 800 mg/day

DRUG

Placebo

Trial Locations (2)

08003

Hospital del Mar, Barcelona

08022

Instituto Poal de Reumatología, Barcelona

Sponsors

Lead Sponsor

Bioiberica
All Listed Sponsors
lead

Bioiberica

INDUSTRY